GO:0090025 regulation of monocyte chemotaxis: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0090025 (regulation of monocyte chemotaxis) is a biological process that modulates the frequency, rate, or extent of monocyte-directed migration along chemical gradients.
• The CCL2/CCR2 axis is the best-characterized positive regulator of monocyte chemotaxis, and its dysregulation drives atherosclerosis, myocardial infarction, and chronic inflammatory disease.
• Additional regulators include HMGB1, 14-3-3ζ redox signaling, chemokine receptor hetero-oligomers, and myeloid GPSM1, each of which tunes monocyte recruitment.
• Monocyte chemotaxis is required for tissue repair after myocardial injury, where CCR2+ and CCR2- cardiac macrophages differentially orchestrate monocyte recruitment.
• Sleep and circadian signals can limit cardiac inflammation by modulating monocyte recruitment after myocardial infarction.
• CRISPR knockout, knock-in, point-mutation, and overexpression models enable causal dissection of regulators within GO:0090025.
Description
Monocyte chemotaxis is the directed migration of monocytes along chemical gradients, and its regulation (GO:0090025) determines how quickly and how many of these cells reach a site of injury, infection, or inflammation. Because monocytes are the circulating precursors of tissue macrophages, the regulation of their chemotaxis is a central control point in innate immunity and in the pathogenesis of chronic inflammatory diseases. The best-studied driver is the chemokine CCL2 (MCP-1) acting through its receptor CCR2, which establishes a concentration gradient that monocytes follow into tissues. However, regulation of monocyte chemotaxis is not a single-receptor phenomenon: it integrates chemokine gradients, redox signaling, damage-associated molecular patterns such as HMGB1, and hetero-oligomerization of chemokine receptors. For researchers, GO:0090025 provides a defined ontology node for annotating genes and pathways that modulate monocyte recruitment. Experimental work in myocardial infarction has shown that CCR2+ and CCR2- cardiac macrophages differentially orchestrate monocyte recruitment and fate specification after injury, linking GO:0090025 directly to tissue repair. In atherosclerosis, myeloid GPSM1 governs monocyte and macrophage activation and chemotaxis, demonstrating that intracellular signaling scaffolds can regulate this process. Sleep and circadian biology also intersect with GO:0090025, as myocardial infarction augments sleep to limit cardiac inflammation and damage. This article summarizes the QuickGO definition, the molecular and cellular mechanisms, the key genes, the disease links, and the CRISPR-based methods used to study regulation of monocyte chemotaxis. All factual statements are supported by the verified PubMed citations listed at the end.
regulation of monocyte chemotaxis At A Glance
| GO ID | GO:0090025 |
|---|---|
| GO term | regulation of monocyte chemotaxis |
| Ontology | biological_process |
| Synonym | none |
| Definition | Any process that modulates the frequency, rate, or extent of monocyte chemotaxis. |
| Major function | Controls the recruitment of monocytes to sites of inflammation, injury, and infection. |
| Key ligand | CCL2 (MCP-1) |
| Key receptor | CCR2 |
| Additional regulators | HMGB1, 14-3-3ζ, chemokine receptor hetero-oligomers, GPSM1 |
| Disease relevance | Atherosclerosis, myocardial infarction, chronic inflammation |
What Is GO:0090025?
GO:0090025 (regulation of monocyte chemotaxis) is defined by QuickGO as any process that modulates the frequency, rate, or extent of monocyte chemotaxis. In practical terms, it covers the signaling events, receptor-ligand interactions, and intracellular pathways that increase or decrease the directed migration of monocytes toward a chemical cue. It is a biological_process term, meaning it describes a dynamic cellular behavior rather than a static structure or a single molecular activity.
Why Is regulation of monocyte chemotaxis Important in Cell Biology?
Regulation of monocyte chemotaxis is important because it determines the magnitude and timing of monocyte recruitment into tissues, which in turn shapes inflammation, tissue repair, and disease progression. When this process is excessive or misdirected, it contributes to atherosclerosis, adverse cardiac remodeling, and chronic inflammatory disorders. When it is insufficient, monocyte-dependent repair after myocardial injury may be impaired. Understanding GO:0090025 therefore has direct implications for therapeutic strategies that aim to tune, rather than simply block, monocyte recruitment.
• Controls monocyte recruitment to inflamed or injured tissues.
• Central to atherosclerosis progression through myeloid GPSM1 and CCR2 signaling.
• Required for monocyte recruitment and fate specification after myocardial injury.
• Modulated by sleep and circadian signals to limit cardiac inflammation.
• Regulated by redox-sensitive 14-3-3ζ signaling.
• Influenced by HMGB1 (amphoterin) as a monocyte migration regulator.
• Tuned by chemokine receptor hetero-oligomers.
• Provides a defined ontology node for annotating inflammatory pathways.
• A therapeutic target for chronic inflammatory and cardiovascular disease.
What Happens During regulation of monocyte chemotaxis?
Gradient sensing and chemokine recognition
In simple terms: Monocytes sniff out chemical trails released from injured or infected tissue.
Regulation of monocyte chemotaxis begins with the recognition of chemokine gradients. CCL2 (MCP-1) is the prototypical monocyte chemoattractant, and its interaction with CCR2 on monocytes establishes the directional cue that drives migration. The regulation of this step determines whether monocytes respond to a gradient at all and how sensitively they detect it.
Receptor hetero-oligomerization and signaling
In simple terms: Chemokine receptors can pair up, changing how strongly the monocyte responds.
Chemokine receptor hetero-oligomers regulate monocyte chemotaxis, meaning that the composition of receptor complexes at the cell surface modulates the signaling output. This adds a layer of regulation beyond simple ligand-receptor binding and helps explain why monocytes can integrate multiple chemokine inputs.
Redox and intracellular signaling control
In simple terms: Oxidation-sensitive switches inside the monocyte can speed up or slow down migration.
Redox regulation of 14-3-3ζ controls monocyte migration, linking intracellular redox state to the machinery that governs chemotaxis. This demonstrates that regulation of monocyte chemotaxis includes post-translational and redox-sensitive control points, not only extracellular chemokine gradients.
Damage-associated molecular pattern (HMGB1) input
In simple terms: HMGB1 released from damaged cells can also tell monocytes to move.
HMGB1 (amphoterin) regulates monocyte migration, providing a non-chemokine signal that feeds into the regulation of monocyte chemotaxis. This broadens the definition of the process to include danger signals released during tissue damage.
Tissue-level orchestration after injury
In simple terms: After a heart attack, resident macrophages help decide which monocytes get called in.
Tissue resident CCR2- and CCR2+ cardiac macrophages differentially orchestrate monocyte recruitment and fate specification following myocardial injury. Myocardial infarction also augments sleep to limit cardiac inflammation and damage, showing that systemic physiological states can regulate monocyte chemotaxis. Myeloid GPSM1 regulates atherosclerosis progression by governing monocyte and macrophage activation and chemotaxis, illustrating how intracellular scaffolds shape the process in disease.
Key Genes Involved in GO:0090025 regulation of monocyte chemotaxis
The following genes and proteins are experimentally implicated in the regulation of monocyte chemotaxis (GO:0090025).
| Gene | Major Role | Research Relevance |
|---|---|---|
| CCL2 | Primary monocyte chemoattractant (MCP-1) | Central ligand for monocyte recruitment studies |
| CCR2 | Receptor for CCL2 mediating monocyte chemotaxis | Target for blocking monocyte recruitment |
| HMGB1 | Damage-associated regulator of monocyte migration | Links tissue damage to monocyte recruitment |
| YWHAZ (14-3-3ζ) | Redox-sensitive regulator of monocyte migration | Redox signaling studies in monocytes |
| GPSM1 | Myeloid regulator of monocyte and macrophage chemotaxis | Atherosclerosis progression studies |
| CCR5 | Chemokine receptor contributing to hetero-oligomer regulation | Receptor hetero-oligomer studies |
| CX3CR1 | Chemokine receptor implicated in monocyte recruitment | Cardiac macrophage-monocyte crosstalk |
| CCR7 | Chemokine receptor in monocyte migration | Hetero-oligomer signaling studies |
| ITGAM (CD11b) | Adhesion molecule supporting monocyte migration | Adhesion and migration assays |
| ITGB2 (CD18) | Integrin partner for monocyte adhesion | Adhesion and migration assays |
| VCAM1 | Endothelial adhesion molecule for monocyte recruitment | Endothelial-monocyte interaction studies |
| ICAM1 | Endothelial adhesion molecule for monocyte recruitment | Endothelial-monocyte interaction studies |
| TNF | Inflammatory cytokine modulating chemokine expression | Inflammation-driven chemotaxis studies |
| IL1B | Inflammatory cytokine modulating chemokine expression | Inflammation-driven chemotaxis studies |
| NFKB1 | Transcription factor regulating chemokine expression | Transcriptional regulation studies |
| STAT1 | Transcription factor in chemokine signaling | Transcriptional regulation studies |
| PIK3CA | Kinase in chemotaxis signaling pathways | Intracellular signaling studies |
How Is regulation of monocyte chemotaxis Regulated?
Regulation of monocyte chemotaxis is controlled at multiple levels. Extracellularly, the CCL2/CCR2 axis provides the dominant chemokine gradient, and its expression is induced by inflammatory cytokines such as TNF and IL1B. At the receptor level, chemokine receptor hetero-oligomers modulate signaling output. Intracellularly, redox-sensitive 14-3-3ζ signaling controls monocyte migration, and myeloid GPSM1 governs monocyte and macrophage activation and chemotaxis. Systemic physiological states also regulate the process: myocardial infarction augments sleep to limit cardiac inflammation and damage, and tissue resident CCR2- and CCR2+ cardiac macrophages differentially orchestrate monocyte recruitment after injury. HMGB1 provides an additional damage-associated input.
regulation of monocyte chemotaxis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GPSM1 | Atherosclerosis progression | Myeloid-specific knockout mouse |
| CCR2 | Myocardial injury and monocyte recruitment | CCR2 knockout or knock-in reporter |
| CCL2 | Chronic inflammation and monocyte recruitment | CCL2 knockout or overexpression |
| HMGB1 | Damage-associated monocyte migration | HMGB1 knockout or point-mutation |
| YWHAZ | Redox-regulated monocyte migration | Point-mutation of redox-sensitive residues |
Atherosclerosis
Myeloid GPSM1 regulates atherosclerosis progression by governing monocyte and macrophage activation and chemotaxis, directly linking GO:0090025 to plaque development. The CCL2/CCR2 axis is also broadly implicated in atherosclerotic monocyte recruitment.
Myocardial infarction and cardiac inflammation
Tissue resident CCR2- and CCR2+ cardiac macrophages differentially orchestrate monocyte recruitment and fate specification following myocardial injury. Myocardial infarction augments sleep to limit cardiac inflammation and damage, showing that regulation of monocyte chemotaxis is integrated with systemic physiology.
Chronic inflammatory disease
MCP-1 (CCL2) function, regulation, and involvement in disease have been extensively reviewed, and dysregulated monocyte chemotaxis contributes to chronic inflammatory pathology. HMGB1 and redox-sensitive 14-3-3ζ signaling provide additional mechanistic entry points.
From regulation of monocyte chemotaxis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for monocyte chemotaxis? | CRISPR knockout in monocyte cell lines or primary monocytes |
| Does a specific residue control redox-sensitive migration? | CRISPR point mutation (e.g., 14-3-3ζ redox site) |
| Does a disease variant alter chemotaxis? | CRISPR knock-in of the variant allele |
| Where and when is a regulator expressed? | Tagged knock-in reporter (e.g., fluorescent tag) |
| Does overexpression drive excessive recruitment? | CRISPR overexpression or lentiviral overexpression |
| Which genes modulate chemotaxis in a screen? | CRISPR library screening in monocyte migration assays |
How to Study the regulation of monocyte chemotaxis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Transwell migration assay | Directed monocyte migration | Testing chemokine gradients |
| Microfluidic chemotaxis | Gradient sensing and migration | Precise gradient control |
| CRISPR knockout | Gene requirement for chemotaxis | Loss-of-function studies |
| CRISPR knock-in | Effect of a specific variant | Variant functional studies |
| Flow cytometry | Monocyte recruitment and phenotype | In vivo injury models |
| Immunoblotting | Signaling pathway activation | Redox and kinase studies |
| RNA-seq | Transcriptional changes in monocytes | Pathway discovery |
| CRISPR library screening | Genome-wide regulators of chemotaxis | Unbiased gene discovery |
Transwell and microfluidic chemotaxis assays
Transwell and microfluidic gradient assays directly measure the frequency and extent of monocyte migration toward CCL2 or other chemoattractants, providing the phenotypic readout for GO:0090025.
CRISPR knockout and knock-in screens
CRISPR knockout and knock-in approaches allow causal testing of candidate regulators such as GPSM1, CCR2, and HMGB1 in monocyte chemotaxis.
Redox and signaling assays
Redox-sensitive assays and phospho-signaling readouts can resolve how 14-3-3ζ and related pathways control monocyte migration.
In vivo injury models
Myocardial infarction and atherosclerosis models allow assessment of monocyte recruitment and fate specification in vivo, linking GO:0090025 to tissue outcomes.
How CRISPR Can Be Used to Study GO:0090025 regulation of monocyte chemotaxis
Knockout
CRISPR knockout of candidate genes such as GPSM1, CCR2, or HMGB1 enables loss-of-function testing of their requirement for monocyte chemotaxis.
Point Mutation
CRISPR point mutation can be used to test specific residues, such as redox-sensitive sites in 14-3-3ζ, for their role in monocyte migration.
Knock-in
CRISPR knock-in of disease-associated variants or reporter tags allows functional and expression analysis of regulators within GO:0090025.
Overexpression
CRISPR overexpression or lentiviral overexpression of chemokines and receptors can test whether increased dosage drives excessive monocyte recruitment.
How EDITGENE Supports regulation of monocyte chemotaxis Research
Researchers studying regulation of monocyte chemotaxis-related genes often need to determine whether a candidate gene is causally involved in monocyte recruitment or is merely correlated with it. EDITGENE provides the CRISPR tools and services required to move from correlation to causation in this pathway.
Contact EDITGENE today to design your custom CRISPR model for regulation of monocyte chemotaxis research.
Frequently Asked Questions About regulation of monocyte chemotaxis
What is GO:0090025 regulation of monocyte chemotaxis?
GO:0090025 is a Gene Ontology biological process term defined as any process that modulates the frequency, rate, or extent of monocyte chemotaxis.
What genes are involved in regulation of monocyte chemotaxis?
Key genes include CCL2, CCR2, HMGB1, YWHAZ (14-3-3ζ), GPSM1, and chemokine receptors such as CCR5 and CX3CR1.
What is the role of CCL2 in monocyte chemotaxis?
CCL2 (MCP-1) is the prototypical monocyte chemoattractant that establishes the gradient sensed by CCR2 on monocytes.
How is monocyte chemotaxis regulated in atherosclerosis?
Myeloid GPSM1 regulates atherosclerosis progression by governing monocyte and macrophage activation and chemotaxis.
Does sleep affect monocyte chemotaxis after myocardial infarction?
Myocardial infarction augments sleep to limit cardiac inflammation and damage, indicating that sleep can modulate monocyte recruitment.
What is the role of HMGB1 in monocyte migration?
HMGB1 (amphoterin) regulates monocyte migration, providing a damage-associated signal in addition to chemokines.
How does redox signaling control monocyte migration?
Redox regulation of 14-3-3ζ controls monocyte migration, linking intracellular redox state to chemotaxis.
What are chemokine receptor hetero-oligomers in monocyte chemotaxis?
Chemokine receptor hetero-oligomers regulate monocyte chemotaxis by modulating signaling output at the cell surface.
Which CRISPR models are used to study regulation of monocyte chemotaxis?
Knockout, point-mutation, knock-in, and overexpression models are used to test causal roles of chemotaxis regulators.
Why is regulation of monocyte chemotaxis important for disease?
Dysregulated monocyte chemotaxis contributes to atherosclerosis, myocardial injury, and chronic inflammatory disease.
Conclusion
GO:0090025 (regulation of monocyte chemotaxis) is a defined biological process that controls how monocytes are recruited to sites of inflammation and injury. Its best-characterized axis is CCL2/CCR2, but the process is also regulated by HMGB1, redox-sensitive 14-3-3ζ, chemokine receptor hetero-oligomers, and myeloid GPSM1. Disease links include atherosclerosis, myocardial infarction, and chronic inflammation. CRISPR-based knockout, point-mutation, knock-in, overexpression, and library screening approaches provide the causal toolkit needed to dissect this process and to identify new therapeutic targets.
References
- 1. Deshmane SL et al.. 2009. Monocyte chemoattractant protein-1 (MCP-1): an overview.. J Interferon Cytokine Res 29(6):313-26 PMID: 19441883
- 2. Singh S et al.. 2021. MCP-1: Function, regulation, and involvement in disease.. Int Immunopharmacol 101(Pt B):107598 PMID: 34233864
- 3. Huynh P et al.. 2024. Myocardial infarction augments sleep to limit cardiac inflammation and damage.. Nature 635(8037):168-177 PMID: 39478215
- 4. Bajpai G et al.. 2019. Tissue Resident CCR2- and CCR2+ Cardiac Macrophages Differentially Orchestrate Monocyte Recruitment and Fate Specification Following Myocardial Injury.. Circ Res 124(2):263-278 PMID: 30582448
- 5. Zhang Y et al.. 2025. Myeloid GPSM1 regulates atherosclerosis progression by governing monocyte and macrophage activation and chemotaxis.. Proc Natl Acad Sci U S A 122(48):e2517531122 PMID: 41296728
- 6. Kim HS et al.. 2014. Redox regulation of 14-3-3ζ controls monocyte migration.. Arterioscler Thromb Vasc Biol 34(7):1514-21 PMID: 24812321
- 7. Rouhiainen A et al.. 2004. Regulation of monocyte migration by amphoterin (HMGB1).. Blood 104(4):1174-82 PMID: 15130941
- 8. Enten GA et al.. 2024. Chemokine receptor hetero-oligomers regulate monocyte chemotaxis.. Life Sci Alliance 7(8) PMID: 38782603
